follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Cancer Genetics Inc. announces IPO pricing

By

Back to Top Comments Print

Latest News

advertisement

Rutherford-based Cancer Genetics Inc., a diagnostics company focused on oncology tests and services, today announced the pricing of its initial public offering of 600,000 shares of its common stock at $10 per share.

The gross proceeds to Cancer Genetics from the initial public offering are expected to be $6 million. The offering is expected to close April 10, subject to customary closing conditions, the company announced.

Write to the Editorial Department at editorial@njbiz.com

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top